Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the withdrawal of the BLA for mRNA-1083, plans for future resubmission of the mRNa-1083 BLA, and anticipated timing for efficacy data for Moderna's seasonal flu vaccine candidate, mRNA-1010. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading "Risk Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date of this press release.
Moderna Contacts
Media:Chris RidleyGlobal Head of Media Relations+1 617-800-3651Chris.Ridley@modernatx.com
Investors:Lavina TalukdarSenior Vice President & Head of Investor Relations+1 617-209-5834Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Tesla Offers Musk $30 Billion to Stay--With Strings Attached
Tesla (NASDAQ:TSLA) just handed CEO Elon Musk a massive new stock awardworth around $30 billiondesigned to keep him anchored at the helm while the company weathers legal battles and business headwinds. The package includes 96 million shares at a $23.34 exercise price, and it only kicks in if Musk stays in a senior leadership role for another two years. It's a stopgap move while the board appeals a court decision that voided his original 2018 compensation plan. That plan, once pegged at $56 billion, has become a flashpoint for investors and governance advocates alike. The interim award signals Tesla's intent to keep Musk focused during a volatile phase for the business. Tesla's board calls this a good faith gestureand timing matters. After a tough first half marked by declining sales, falling revenue, and a 25% YTD drop in share price, the company is leaning heavily on Musk's leadership to navigate what it describes as a critical inflection point. According to Wedbush analyst Dan Ives, the new agreement helps remove a lingering cloud over the stock and likely cements Musk's role for the foreseeable future. The board is also developing a longer-term pay structure, to be voted on at the November 6 shareholder meeting. But leadership retention isn't the only thing on the line. Musk's attention has been split across multiple venturesSpaceX, xAI, X Corp, Neuralink, The Boring Companyand his recent political entanglements haven't helped. The board acknowledges these distractions but says Musk remains central to Tesla's ability to attract and retain talent. Meanwhile, Tesla is trying to build momentum around its new robotaxi program, launched in Austin, which could be a long-term growth lever. Whether this compensation reset keeps Musk focused on Teslaor just buys timeis what investors will be watching next. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
38 minutes ago
- Yahoo
Wells Fargo cuts Lululemon target on margin pressure
-- Wells Fargo lowered its price target on Lululemon Athletica (NASDAQ:LULU) to $225 from $270 and reiterated an Equal Weight rating, citing persistent weakness in U.S. trends, margin pressures in China, and increasing headwinds from markdowns and tariffs. The firm said Lululemon's near-term outlook remains difficult, and further estimate cuts are likely. It reduced its FY2025 EPS forecast to $14.60, near the low end of the company's guidance, and took down FY2026 EPS to $14.90, well below consensus at $15.52. The reduced target is based on a 15x multiple, which Wells described as 'trough-level' but warranted given the risk of 'over-earning' and ongoing execution missteps. Wells flagged weak North America trends, with 2Q comps likely flat to slightly positive, driven more by clearance activity than underlying demand. Despite some success with new fabrics and styles, the firm said the return of more color has not reignited interest among U.S. consumers. In China, growth appears to be slowing after a sharp sequential decline last quarter. The firm cut its 3Q/4Q China comp forecasts to +12% and +10%, down from prior expectations of +15% for both quarters. Given China's higher margin profile, any softness there could pose a risk to the company's profitability going forward. Markdowns have increased in July, and tariff-related costs, particularly from Vietnam, could shave 50-100 basis points from margins in late 2025 into 2026. Wells lowered its 3Q and 4Q gross margin assumptions by 25bps as a result. Bottom line, the firm sees limited near-term upside as Lululemon navigates softening demand and growing cost pressures. Related articles Wells Fargo cuts Lululemon target on margin pressure Clients buying into summer rally, bracing for later pullback, says BofA's Hartnett If Powell goes, does Fed trust go with him?
Yahoo
38 minutes ago
- Yahoo
Markets Await Factor Orders Data
Pre-market futures are back in the green this morning, after a dramatic shakeout on Friday that saw a disappointing jobs report lead to the firing of the Chief of the U.S. Bureau of Labor Statistics (BLS). We now officially see a labor market slowdown with drastic downward revisions to the prior two months, and this means that interest rates are likely to come down. To wit, bond yields have shrunk. The 10-year has dissolved back to 4.20%, where it hasn't been since late April. The 2-year is also at 3+ month lows, +3.67%. The odds that the Fed funds rate gets reduced from its current 4.25-4.50% at its next Federal Open Market Committee meeting (mid-September) are now near-certain. In fact, the odds for a third rate cut this year have grown, as well. The Dow is currently up +195 points ahead of the new trading week, with the S&P 500 at +33 and the Nasdaq +188 points. The small-cap Russell 2000 is up +13. For the month of July — which had performed excellently for the most part — closed in the red for the Dow and Russell 2000, in the green for the Nasdaq and S&P 500. August tends to be a weaker trading month, historically. However, as Q2 earnings reports continue to file in — more than 500 companies will report on Wednesday alone — and outperform expectations, if they can also raise guidance based on what they see unfolding in the economy, there is a chance for a surprise to the upside this month. Economic reports throughout the month will likely contribute to this forming narrative, as well. Wayfair Posts Big Earnings Surprise, Tyson Beats Ahead of today's open, furniture retailer Wayfair (W) posted a huge +141.67% positive surprise, with earnings of 87 cents per share far ahead of the 36 cents in the Zacks consensus. The Zacks Rank #2 (Buy)-rated company also posted a +4.25% revenue beat this morning, with $3.27 billion reported on the top line. Shares are up +13% on the news, adding to its +47.2% growth year to date. Tyson Foods (TSN) also outpaced estimates in its fiscal Q3 report this morning, albeit not by as wide of margins. Earnings of 91 cents per share surpassed the 72 cents, for a positive earnings surprise of +26.39%, on revenues of $13.88 billion bettering the Zacks consensus by +1.88%. Shares are trading up +5% in today's pre-market, making up for most of the stock's -8.5% loss year to date. What to Expect from the Stock Market Today After the opening bell this morning, we'll take a look at Factory Orders for the month of June. These are expected to shift to a negative month over month: -4.9% from +8.2% the prior month, which was the highest single-month tally in more than 10 years. A negative print would be the second in the past three months, so we see these numbers clumping a bit. Cybersecurity favorite Palantir (PLTR) reports Q2 earnings after today's close. The stock, currently registering as a Zacks Rank #5 (Strong Sell), is expected to gain +55.56% on earnings year over year and +38.37% on revenues. Even with Friday's $4 selloff per share, Palantir shares are still trading over +100% year to date. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tyson Foods, Inc. (TSN) : Free Stock Analysis Report Wayfair Inc. (W) : Free Stock Analysis Report Palantir Technologies Inc. (PLTR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
